Search - tctmd.com

Displaying 1 - 13 of 13

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

November 02, 2017

$First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease$

Presentation TCT 2017

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

Presenter: Daniel Burkhoff, Samir R. Kapadia, Alaide Chieffo

November 01, 2017

$My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!$

Presentation TCT 2017

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Presenter: Timothy D. Henry, Marc S. Penn

October 31, 2017

Presentation TCT 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor

October 31, 2017

Presentation TCT 2017

New Strategies: Repetitive Injections

Presenter: Timothy D. Henry, Marc S. Penn, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

New Trials: REGENT-VSEL

Presenter: Timothy D. Henry, Marc S. Penn, Wojtek Wojakowski

October 31, 2017

$Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)$

Presentation TCT 2017

Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)

Presenter: Philippe Genereux, Simon J. Walsh, Stefan Verheye

October 30, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

$Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It$

News Conference News SCAI 2017

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

L.A. McKeown

May 19, 2017

News Daily News

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

Michael O'Riordan

April 11, 2017

News Conference News ACC 2017

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

Yael L. Maxwell

March 19, 2017

$The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina$

Presentation JIM 2017

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

Presenter: Francesco Giannini

February 10, 2017

News Industry News

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

February 07, 2017

Advertisement

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Critical Limb Ischemia Update, and the STOP-PAD Trial

New Strategies: Repetitive Injections

New Trials: REGENT-VSEL

Special Lecture: Treatment of Refractory Angina - Reducer-1 European Registry and US Approval Trial (With Discussion)

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Access Denied: Stem Cell Therapy Shows Some Promise in Refractory Angina, but Patients Can’t Get It

ICTUS: No Benefit at 10 Years With Early Invasive Strategy in NSTE ACS Patients

DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions

The Coronary Sinus Reducer: A Device Based Therapy for Refractory Angina

FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content